Core Laboratories (CLB) Stock Price, News & Analysis

Company Overview

Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.

The company’s portfolio spans two primary service lines: reservoir description and production enhancement. In reservoir description, Core Laboratories performs detailed analyses on drill-cuttings, cores and reservoir fluids to characterize rock and fluid properties. Under production enhancement, the company offers well stimulation, downhole chemistry, and scale and corrosion management solutions designed to improve flow rates and mitigate operational risks. These services are supported by a global network of research laboratories and field service centers equipped with advanced instrumentation.

Headquartered in Amsterdam with key operating offices in Houston, Core Laboratories conducts business in more than 50 countries across six continents, serving major international and national oil companies, as well as independents. The company’s engineering and technical teams collaborate closely with clients to tailor solutions to diverse reservoir environments. Under the leadership of President and CEO Clay C. Williams, Core Laboratories continues to invest in innovation and technology development to address evolving challenges in reservoir management and production optimization.

Key Stats

• Today's Range: $13.61 to $14.16
• 50-Day Range: $13.69 to $17.61
• 52-Week Range: $9.72 to $20.36
• Volume: 472,718 shs
• Average Volume: 458,252 shs
• Market Capitalization: $631.20 million
• P/E Ratio: 21.06
• Dividend Yield: 0.29%
• Price Target: $12.50
• Consensus Rating: Hold

Core Laboratories Stock Analysis - MarketRank™

Core Laboratories scored higher than 35% of companies evaluated by MarketBeat, and ranked 193rd out of 247 stocks in the energy sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.2 / 5
• Analyst Rating: Hold

Consensus Rating

Core Laboratories has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, no buy ratings, 4 hold ratings, and no sell ratings.

Downside Risk

Core Laboratories has a consensus price target of $12.50, representing about 8.7% downside from its current price of $13.69.

Amount of Analyst Coverage

Core Laboratories has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 45.61%

Earnings Growth

Earnings for Core Laboratories are expected to grow by 45.61% in the coming year, from $0.57 to $0.83 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Core Laboratories is 21.06, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 42.35.

Price to Earnings Ratio vs. Sector

The P/E ratio of Core Laboratories is 21.06, which means that it is trading at a more expensive P/E ratio than the Energy sector average P/E ratio of about 14.86.

Price to Earnings Growth Ratio

Core Laboratories has a PEG Ratio of 2.68. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Core Laboratories has a P/B Ratio of 2.29. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for CLB.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Core Laboratories has a dividend yield of 0.28%, which is in the bottom 25% of all stocks that pay dividends.

Dividend Growth

Core Laboratories does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Core Laboratories is 6.15%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Core Laboratories will have a dividend payout ratio of 4.82% next year. This indicates that Core Laboratories will be able to sustain or increase its dividend.

News and Social Media

• Score: 2.7 / 5
• News Sentiment: 0.29

News Sentiment

Core Laboratories has a news sentiment score of 0.29. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.66 average news sentiment score of Energy companies.

News Coverage This Week

MarketBeat has tracked 12 news articles for Core Laboratories this week, compared to 1 article on an average week.

Search Interest

1 people have searched for CLB on MarketBeat in the last 30 days.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Core Laboratories insiders have not sold or bought any company stock.

Percentage Held by Insiders

1.26% of the stock of Core Laboratories is held by insiders.

Percentage Held by Institutions

97.81% of the stock of Core Laboratories is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

CLB Stock Analysis - Frequently Asked Questions

How have CLB shares performed this year?

Core Laboratories' stock was trading at $16.02 at the start of the year. Since then, CLB shares have decreased by 14.5% and is now trading at $13.6920.

How were Core Laboratories' earnings last quarter?

Core Laboratories Inc. (NYSE:CLB) announced its quarterly earnings data on Wednesday, April, 29th. The oil and gas company reported $0.06 EPS for the quarter, hitting analysts' consensus estimates of $0.06. The business's revenue for the quarter was down 1.4% on a year-over-year basis.
Read the conference call transcript.

Who are Core Laboratories' major shareholders?

Core Laboratories' top institutional shareholders include Bank of New York Mellon Corp (0.88%), Principal Financial Group Inc. (0.59%), Illinois Municipal Retirement Fund (0.06%) and Kornitzer Capital Management Inc. KS (0.05%).
View institutional ownership trends.

How do I buy shares of Core Laboratories?

Shares of CLB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Core Laboratories own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Core Laboratories investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), AUO (AUOTY) and DiamondRock Hospitality (DRH).

Company Calendar

• Ex-Dividend for 3/9 Dividend: 2/13/2026
• Record date for 3/9 Dividend: 2/16/2026
• Dividend Payable: 3/09/2026
• Last Earnings: 4/29/2026
• Today: 5/06/2026
• Record date for 6/1 Dividend: 5/11/2026
• Ex-Dividend for 6/1 Dividend: 5/11/2026
• Dividend Payable: 6/01/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Energy
• Industry: OIL - FIELD SVCS
• Sub-Industry: Petroleum And Natural Gas
• Current Symbol: NYSE:CLB
• CIK: 1958086
• Web: www.corelab.com
• Phone: (713) 328-2673
• Fax: N/A
• Employees: 3,300
• Year Founded: 1936

Price Target and Rating

• Average Price Target for Core Laboratories: $12.50
• High Price Target: $13.00
• Low Price Target: $12.00
• Potential Upside/Downside: -8.7%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 4 Analysts

Profitability

• EPS (Trailing Twelve Months): $0.65
• Trailing P/E Ratio: 21.06
• Forward P/E Ratio: 24.02
• P/E Growth: 2.68
• Net Income: $29.67 million
• Net Margins: 5.94%
• Pretax Margin: 8.21%
• Return on Equity: 11.52%
• Return on Assets: 5.32%

Debt

• Debt-to-Equity Ratio: 0.42
• Current Ratio: 2.05
• Quick Ratio: 1.50

Sales & Book Value

• Annual Sales: $526.52 million
• Price / Sales: 1.20
• Cash Flow: $1.03 per share
• Price / Cash Flow: 13.32
• Book Value: $5.97 per share
• Price / Book: 2.29

Miscellaneous

• Outstanding Shares: 46,100,000
• Free Float: 45,516,000
• Market Cap: $631.20 million
• Optionable: Optionable
• Beta: 0.99